QQQ   281.49 (+2.91%)
AAPL   145.84 (+2.38%)
MSFT   248.43 (+3.19%)
META   139.98 (+0.99%)
GOOGL   101.35 (+2.75%)
AMZN   120.94 (+4.37%)
TSLA   248.71 (+2.60%)
NVDA   131.20 (+4.86%)
NIO   16.67 (+7.62%)
BABA   83.94 (+4.34%)
AMD   67.84 (+2.62%)
T   16.08 (+1.13%)
MU   53.89 (+4.20%)
CGC   3.14 (+7.90%)
F   12.34 (+7.59%)
GE   67.36 (+5.91%)
DIS   101.22 (+4.21%)
AMC   7.85 (+14.10%)
PYPL   92.53 (+6.14%)
PFE   44.39 (+0.57%)
NFLX   240.19 (+0.48%)
QQQ   281.49 (+2.91%)
AAPL   145.84 (+2.38%)
MSFT   248.43 (+3.19%)
META   139.98 (+0.99%)
GOOGL   101.35 (+2.75%)
AMZN   120.94 (+4.37%)
TSLA   248.71 (+2.60%)
NVDA   131.20 (+4.86%)
NIO   16.67 (+7.62%)
BABA   83.94 (+4.34%)
AMD   67.84 (+2.62%)
T   16.08 (+1.13%)
MU   53.89 (+4.20%)
CGC   3.14 (+7.90%)
F   12.34 (+7.59%)
GE   67.36 (+5.91%)
DIS   101.22 (+4.21%)
AMC   7.85 (+14.10%)
PYPL   92.53 (+6.14%)
PFE   44.39 (+0.57%)
NFLX   240.19 (+0.48%)
QQQ   281.49 (+2.91%)
AAPL   145.84 (+2.38%)
MSFT   248.43 (+3.19%)
META   139.98 (+0.99%)
GOOGL   101.35 (+2.75%)
AMZN   120.94 (+4.37%)
TSLA   248.71 (+2.60%)
NVDA   131.20 (+4.86%)
NIO   16.67 (+7.62%)
BABA   83.94 (+4.34%)
AMD   67.84 (+2.62%)
T   16.08 (+1.13%)
MU   53.89 (+4.20%)
CGC   3.14 (+7.90%)
F   12.34 (+7.59%)
GE   67.36 (+5.91%)
DIS   101.22 (+4.21%)
AMC   7.85 (+14.10%)
PYPL   92.53 (+6.14%)
PFE   44.39 (+0.57%)
NFLX   240.19 (+0.48%)
QQQ   281.49 (+2.91%)
AAPL   145.84 (+2.38%)
MSFT   248.43 (+3.19%)
META   139.98 (+0.99%)
GOOGL   101.35 (+2.75%)
AMZN   120.94 (+4.37%)
TSLA   248.71 (+2.60%)
NVDA   131.20 (+4.86%)
NIO   16.67 (+7.62%)
BABA   83.94 (+4.34%)
AMD   67.84 (+2.62%)
T   16.08 (+1.13%)
MU   53.89 (+4.20%)
CGC   3.14 (+7.90%)
F   12.34 (+7.59%)
GE   67.36 (+5.91%)
DIS   101.22 (+4.21%)
AMC   7.85 (+14.10%)
PYPL   92.53 (+6.14%)
PFE   44.39 (+0.57%)
NFLX   240.19 (+0.48%)
OTCMKTS:CBSC

CB Scientific - CBSC Competitors

$0.19
0.00 (0.00%)
(As of 10/3/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.19
$0.19
50-Day Range
$0.14
$0.27
52-Week Range
$0.11
$0.95
Volume
N/A
Average Volume
18,076 shs
Market Capitalization
$22.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CBSC vs. SRGA, ONCR, BCAC, EFTR, ATNF, ATBPF, TNXP, ACER, ALRT, and RGRX

Should you be buying CB Scientific stock or one of its competitors? The main competitors of CB Scientific include Surgalign (SRGA), Oncorus (ONCR), Brookline Capital Acquisition (BCAC), eFFECTOR Therapeutics (EFTR), 180 Life Sciences (ATNF), Antibe Therapeutics (ATBPF), Tonix Pharmaceuticals (TNXP), Acer Therapeutics (ACER), ALR Technologies (ALRT), and RegeneRx Biopharmaceuticals (RGRX). These companies are all part of the "medical" sector.

CB Scientific vs.

Surgalign (NASDAQ:SRGA) and CB Scientific (OTCMKTS:CBSC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, community ranking, analyst recommendations, profitability and valuation.

Surgalign has a beta of 1.96, suggesting that its share price is 96% more volatile than the S&P 500. Comparatively, CB Scientific has a beta of 2.38, suggesting that its share price is 138% more volatile than the S&P 500.

In the previous week, Surgalign had 3 more articles in the media than CB Scientific. MarketBeat recorded 4 mentions for Surgalign and 1 mentions for CB Scientific. CB Scientific's average media sentiment score of 0.99 beat Surgalign's score of 0.37 indicating that CB Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgalign
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CB Scientific
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CB Scientific has a net margin of 0.00% compared to Surgalign's net margin of -70.49%. CB Scientific's return on equity of 0.00% beat Surgalign's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgalign -70.49% -234.38% -47.02%
CB Scientific N/A N/A N/A

14.9% of Surgalign shares are held by institutional investors. 10.3% of Surgalign shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Surgalign presently has a consensus price target of $48.75, suggesting a potential upside of 1,203.48%. Given Surgalign's higher probable upside, equities analysts clearly believe Surgalign is more favorable than CB Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgalign
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
CB Scientific
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

CB Scientific has lower revenue, but higher earnings than Surgalign.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgalign$90.50 million0.28-$84.65 million-$12.57-0.30
CB ScientificN/AN/AN/AN/AN/A

Surgalign received 9 more outperform votes than CB Scientific when rated by MarketBeat users.

CompanyUnderperformOutperform
SurgalignOutperform Votes
9
50.00%
Underperform Votes
9
50.00%
CB ScientificN/AN/A

Summary

Surgalign beats CB Scientific on 7 of the 12 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CBSC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CBSC vs. The Competition

MetricCB Scientific IndustryMedical SectorOTCMKTS Exchange
Market Cap$22.71M$1.91B$4.18B$6.35B
Dividend YieldN/A15.72%7.99%37.38%
P/E RatioN/A2.0291.212.13
Price / SalesN/A351.813,328.79563.33
Price / CashN/A100.7820.8917.99
Price / BookN/A1.205.926.42
Net IncomeN/A$915.89M$162.61M$746.35M
7 Day Performance-4.04%2.23%4.13%0.62%
1 Month Performance-23.97%-3.81%-6.68%-5.30%
1 Year Performance-12.44%-14.54%-34.42%69.92%

CB Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRGA
Surgalign
1.9388 of 5 stars
$3.50
+1.4%
$47.50
+1,257.1%
-88.8%$23.61M$90.50M-0.28231Gap Up
ONCR
Oncorus
2.2461 of 5 stars
$0.91
+3.4%
$7.75
+750.8%
-90.9%$23.58MN/A-0.3282Gap Up
BCAC
Brookline Capital Acquisition
0 of 5 stars
$3.47
-15.8%
N/AN/A$23.41MN/A0.006Gap Down
High Trading Volume
EFTR
eFFECTOR Therapeutics
2.6475 of 5 stars
$0.56
flat
$11.30
+1,903.2%
-95.7%$23.38M$1.43M0.7412Positive News
Gap Up
ATNF
180 Life Sciences
0 of 5 stars
$0.70
+2.9%
N/A-87.6%$23.96MN/A1.672Positive News
ATBPF
Antibe Therapeutics
0 of 5 stars
$0.45
flat
N/A-50.7%$23.35M$7.67M0.0047Short Interest ↓
Positive News
TNXP
Tonix Pharmaceuticals
2.1922 of 5 stars
$0.54
+1.9%
$19.20
+3,484.8%
-97.1%$23.99MN/A-0.0873News Coverage
Positive News
Gap Up
ACER
Acer Therapeutics
2.1041 of 5 stars
$1.45
+7.4%
$12.00
+727.6%
-44.3%$23.12M$1.26M-1.0735Short Interest ↑
News Coverage
Positive News
Gap Up
ALRT
ALR Technologies
0 of 5 stars
$0.04
flat
N/A-34.5%$23.07M$10,000.000.001
RGRX
RegeneRx Biopharmaceuticals
0 of 5 stars
$0.16
+6.7%
N/A+0.3%$22.97M$80,000.000.003
This page (OTCMKTS:CBSC) was last updated on 10/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.